Amedisys (AMED) Tops Q3 EPS by 2c, Miss on Revenues

Amedisys (NASDAQ: AMED) reported Q3 EPS of $0.56, $0.02 better than the analyst estimate of $0.54. Revenue for the quarter came in at $380.2 million versus the consensus estimate of $385.5 million.

Three Month Periods Ended September 30, 2017 and 2016

• Net service revenue increased $18.6 million to $380.2 million compared to $361.6 million in 2016.
• Net income attributable to Amedisys, Inc. of $14.6 million compared to $11.4 million in 2016.
• Net income attributable to Amedisys, Inc. per diluted share of $0.42 compared to $0.34 in 2016.

Adjusted Quarterly Results*

• Adjusted EBITDA of $36.9 million compared to $25.6 million in 2016.
• Adjusted net service revenue of $386.7 million compared to $361.6 million in 2016.
• Adjusted net income attributable to Amedisys, Inc. of $19.2 million compared to $12.1 million in 2016.
• Adjusted net income attributable to Amedisys, Inc. per diluted share of $0.56 compared to $0.36 in 2016.

For earnings history and earnings-related data on Amedisys (AMED) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Academy Sports and Outdoor (ASO) Misses Q1 EPS by 1c ; Offers Guidance
• Cracker Barrel (CBRL) Tops Q3 EPS by 71c